Go to content
UR Home

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Lengfelder, E. ; Haferlach, C. ; Saussele, S. ; Haferlach, T. ; Schultheis, B. ; Schnittger, S. ; Ludwig, W.-D. ; Staib, P. ; Aul, C. ; Grüneisen, A. ; Kern, W. ; Reichle, A. ; Serve, H. ; Berdel, W. E. ; Braess, J. ; Spiekermann, K. ; Wörmann, B. ; Sauerland, M.-C. ; Heinecke, A. ; Hiddemann, W. ; Hehlmann, R. ; Büchner, T.



Abstract

The objective of this study for newly diagnosed acute promyelocytic Leukemia (APL) was to evaluate the efficacy of an intensified double induction chemotherapy including high dose ara-C (HD) and all-trans retinoic acid (ATRA) followed by consolidation and 3 years maintenance therapy. In contrast to APL studies stratifying therapy according to pretreatment white blood cell (WBC) count < and >= 10 ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons